Literature DB >> 16935465

A comparison of the neurotropism of Theiler's virus and poliovirus in CBA mice.

D Villarreal1, C R Young, R Storts, J W Ting, C J R Welsh.   

Abstract

Theiler's murine encephalomyelitis virus (TMEV) and poliovirus infect the central nervous system (CNS) and cause neurological damage. The exact route by which TMEV and polioviruses enter the CNS remains, for the most part, unknown, although the neural and/or the hematogenous pathway have both been postulated. To explore these hypotheses, this research focuses on both the site of entry and the pathway used to invade the CNS. Following different inoculation sites of the GDVII strain of Theiler's virus or Lansing Type 2 poliovirus in CBA mice, the incidence of paralysis and/or encephalitis was evaluated on the basis of clinical signs and histopathology. The forms of paralysis displayed corresponded to the site of viral inoculation. Following intramuscular (i.m.), intraperitoneal (i.p.), and footpad routes of injection, bilateral and or contralateral paralyses were observed for both TMEV and poliovirus. In mice injected intratongue and in the hypoglossal nerve, tongue paralysis or paralysis of the forelimb, which progressed to bilateral forelimb paralysis, was observed, additionally the penis of most infected males was protruded. Intracranial (i.c.) injections with type II poliovirus strain resulted in forelimb paralysis. Intravenous (i.v.), injections with TMEV also resulted in forelimb paralysis. Thus Lansing Type II poliovirus and TMEV infections of CBA mice, result in similar incidence of paralysis and histopathological findings.

Entities:  

Mesh:

Year:  2006        PMID: 16935465     DOI: 10.1016/j.micpath.2006.01.009

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  8 in total

1.  Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism.

Authors:  G Loughran; J E Libbey; S Uddowla; M F Scallan; M D Ryan; R S Fujinami; E Rieder; J F Atkins
Journal:  J Gen Virol       Date:  2012-10-24       Impact factor: 3.891

Review 2.  Virus infection, antiviral immunity, and autoimmunity.

Authors:  Daniel R Getts; Emily M L Chastain; Rachael L Terry; Stephen D Miller
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

3.  Enhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T Cells.

Authors:  Michael P Bell; Kevin D Pavelko
Journal:  Mol Cancer Ther       Date:  2016-01-28       Impact factor: 6.261

4.  Cannabinoids and Viral Infections.

Authors:  Carol Shoshkes Reiss
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-01

5.  Theiler's murine encephalomyelitis virus attachment to the gastrointestinal tract is associated with sialic acid binding.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neurovirol       Date:  2008-12-26       Impact factor: 2.643

6.  Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models.

Authors:  Osamu Kotani; Asif Naeem; Tadaki Suzuki; Naoko Iwata-Yoshikawa; Yuko Sato; Noriko Nakajima; Takushi Hosomi; Hiroyuki Tsukagoshi; Kunihisa Kozawa; Hideki Hasegawa; Fumihiro Taguchi; Hiroyuki Shimizu; Noriyo Nagata
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

7.  Comparison of Theiler's Murine Encephalomyelitis Virus Induced Spinal Cord and Peripheral Nerve Lesions Following Intracerebral and Intraspinal Infection.

Authors:  Wen Jin; Eva Leitzen; Sandra Goebbels; Klaus-Armin Nave; Wolfgang Baumgärtner; Florian Hansmann
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

8.  Clinical and histopathological studies on neurodegeneration and dysautonomia in buffalo calves during foot-and-mouth disease outbreaks in Egypt.

Authors:  Yasmin Bayoumi; Nader Sobhy; Abdelkarem Morsi; Wafaa El-Neshwey; Nora El-Seddawy; Abdelmonem Abdallah
Journal:  Vet World       Date:  2021-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.